Aberrations in peripheral B lymphocytes and B lymphocyte subsets levels in Parkinson disease: a systematic review
The association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD pa...
Saved in:
Published in | Frontiers in immunology Vol. 16; p. 1526095 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
31.03.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD patients,it is necessary to conduct a systematic review on this subject.
PubMed, Cochrane Library, and MEDLINE databases were searched until 3
February 2024.
We included 20 studies (n=2658) to conduct this systematic review. We conducted a qualitative analysis to assess the alterations of B lymphocytes and B lymphocyte subsets in the peripheral blood of individuals with PD. And studies reviewed demonstrated a significant decrease in the number of B cells, as well as immune dysregulation in the B lymphocyte subsets of these patients' peripheral blood.
Studies reviewed demonstrated that PD is linked to abnormalities in B lymphocytes and/or B lymphocytes subsets in peripheral blood. This study provides a novel perspective into the pathogenesis of PD, and future investigations into the B lymphocytes and/or B lymphocyte subsets as biomarkers and therapeutic targets for PD is warranted. |
---|---|
AbstractList | The association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD patients,it is necessary to conduct a systematic review on this subject.
PubMed, Cochrane Library, and MEDLINE databases were searched until 3
February 2024.
We included 20 studies (n=2658) to conduct this systematic review. We conducted a qualitative analysis to assess the alterations of B lymphocytes and B lymphocyte subsets in the peripheral blood of individuals with PD. And studies reviewed demonstrated a significant decrease in the number of B cells, as well as immune dysregulation in the B lymphocyte subsets of these patients' peripheral blood.
Studies reviewed demonstrated that PD is linked to abnormalities in B lymphocytes and/or B lymphocytes subsets in peripheral blood. This study provides a novel perspective into the pathogenesis of PD, and future investigations into the B lymphocytes and/or B lymphocyte subsets as biomarkers and therapeutic targets for PD is warranted. The association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD patients,it is necessary to conduct a systematic review on this subject.ObjectiveThe association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD patients,it is necessary to conduct a systematic review on this subject.PubMed, Cochrane Library, and MEDLINE databases were searched until 3rd February 2024.MethodsPubMed, Cochrane Library, and MEDLINE databases were searched until 3rd February 2024.We included 20 studies (n=2658) to conduct this systematic review. We conducted a qualitative analysis to assess the alterations of B lymphocytes and B lymphocyte subsets in the peripheral blood of individuals with PD. And studies reviewed demonstrated a significant decrease in the number of B cells, as well as immune dysregulation in the B lymphocyte subsets of these patients' peripheral blood.ResultsWe included 20 studies (n=2658) to conduct this systematic review. We conducted a qualitative analysis to assess the alterations of B lymphocytes and B lymphocyte subsets in the peripheral blood of individuals with PD. And studies reviewed demonstrated a significant decrease in the number of B cells, as well as immune dysregulation in the B lymphocyte subsets of these patients' peripheral blood.Studies reviewed demonstrated that PD is linked to abnormalities in B lymphocytes and/or B lymphocytes subsets in peripheral blood. This study provides a novel perspective into the pathogenesis of PD, and future investigations into the B lymphocytes and/or B lymphocyte subsets as biomarkers and therapeutic targets for PD is warranted.ConclusionStudies reviewed demonstrated that PD is linked to abnormalities in B lymphocytes and/or B lymphocytes subsets in peripheral blood. This study provides a novel perspective into the pathogenesis of PD, and future investigations into the B lymphocytes and/or B lymphocyte subsets as biomarkers and therapeutic targets for PD is warranted. ObjectiveThe association of B lymphocytes and B lymphocyte subsets and Parkinson’s disease (PD) is increasingly acknowledged. However, there is inconsistence in the alterations of B lymphocytes or B lymphocyte subsets in peripheral blood of PD patients. To comprehensively understand its changes in PD patients,it is necessary to conduct a systematic review on this subject.MethodsPubMed, Cochrane Library, and MEDLINE databases were searched until 3rd February 2024.ResultsWe included 20 studies (n=2658) to conduct this systematic review. We conducted a qualitative analysis to assess the alterations of B lymphocytes and B lymphocyte subsets in the peripheral blood of individuals with PD. And studies reviewed demonstrated a significant decrease in the number of B cells, as well as immune dysregulation in the B lymphocyte subsets of these patients’ peripheral blood.ConclusionStudies reviewed demonstrated that PD is linked to abnormalities in B lymphocytes and/or B lymphocytes subsets in peripheral blood. This study provides a novel perspective into the pathogenesis of PD, and future investigations into the B lymphocytes and/or B lymphocyte subsets as biomarkers and therapeutic targets for PD is warranted. |
Author | Wang, Ziyuan Yu, Miao Yan, Junqiang Zhai, Yibo Ma, Hongxia |
AuthorAffiliation | 1 Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology , Luoyang , China 2 Key laboratory of Neuromolecular Biology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology , Luoyang , China |
AuthorAffiliation_xml | – name: 1 Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology , Luoyang , China – name: 2 Key laboratory of Neuromolecular Biology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology , Luoyang , China |
Author_xml | – sequence: 1 givenname: Hongxia surname: Ma fullname: Ma, Hongxia – sequence: 2 givenname: Ziyuan surname: Wang fullname: Wang, Ziyuan – sequence: 3 givenname: Miao surname: Yu fullname: Yu, Miao – sequence: 4 givenname: Yibo surname: Zhai fullname: Zhai, Yibo – sequence: 5 givenname: Junqiang surname: Yan fullname: Yan, Junqiang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40230858$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkktv1DAUhS1URNuhf4AF8pLNDH4nZoNKRaFSJVjA2rKd645LEqd2Mmj-PZkHVccbW9fH37m6PpforE89IPSOkhXntf4YYtdNK0aYXFHJFNHyFbqgSoklZ0ycvTifo6tSHsm8hOacyzfoXBDGSS3rC_R07SBnO8bUFxx7PECOwxqybfEX3G67YZ38doSCbd-cVHCZXIGx4BY20O7f_rT5T-xL6nETC9gCn7DFZVtG6GYDjzNsIvx9i14H2xa4Ou4L9Pv266-b78v7H9_ubq7vl14wNi659cqpKjQuKCmBOA01MA-VVFQIQpvah8pKF7STNeGqanRDVfCWWh-cbPgC3R24TbKPZsixs3lrko1mX0j5wdg8t9WCAc5BVILtHASvrWa-scoHJiQoyd3M-nxgDZProPHQj_OETqCnN31cm4e0MZRqLap52gv04UjI6WmCMpouFg9ta3tIUzGcasK5YpTO0vcvzZ5d_n_aLGAHgc-plAzhWUKJ2YXD7MNhduEwx3DwfzJksLY |
Cites_doi | 10.1097/NEN.0b013e31818e5e99 10.1155/2013/952375 10.1016/j.cell.2010.02.029 10.1111/imr.v303.1 10.3727/096368908784423328 10.1016/S1474-4422(18)30499-X 10.1016/j.jneuroim.2010.12.001 10.1038/s41582-023-00902-2 10.1093/intimm/dxl080 10.1016/S0140-6736(23)01478-2 10.1007/s12035-017-0404-y 10.1007/s10654-010-9491-z 10.3233/JPD-223418 10.1016/j.cell.2014.04.005 10.1021/acschemneuro.7b00063 10.1038/s41593-018-0213-2 10.1182/blood-2008-02-078071 10.1172/JCI85113 10.1371/journal.pone.0018513 10.1007/s12264-017-0163-9 10.1016/j.jneuroim.2012.07.015 10.1016/j.nrl.2018.10.004 10.3233/JPD-202221 10.1038/s41593-018-0227-9 10.3389/fimmu.2022.903711 10.3389/fneur.2020.572205 10.1016/S1474-4422(24)00038-3 10.1126/sciimmunol.abm9060 10.1016/j.pneurobio.2018.08.002 10.1111/j.1447-0594.2011.00740.x 10.1016/j.jneuroim.2016.05.004 10.3233/JAD-142412 10.1056/NEJMoa1610528 10.1186/1750-1326-6-66 10.1016/S0140-6736(21)00218-X 10.1177/1352458520951536 10.3389/fneur.2022.808322 10.1080/14728222.2020.1821647 10.1146/annurev-immunol-020711-074934 10.1186/s12974-019-1606-1 10.1016/S0140-6736(14)61393-3 10.1146/annurev-immunol-092419-031130 10.1038/nri.2017.76 10.21037/atm.2019.10.105 10.1001/jama.2019.22360 10.1038/ni833 10.4049/jimmunol.178.10.6624 10.1172/JCI36470 10.1186/s40035-019-0147-y 10.1016/j.exger.2017.07.002 10.1084/jem.20072683 10.1212/NXI.0000000000001036 10.1016/j.coi.2021.06.014 10.1073/pnas.1416276112 10.1016/j.immuni.2015.04.005 10.1189/jlb.3A0414-213RR 10.1093/cei/uxac104 10.1093/braincomms/fcad060 10.1186/s12974-019-1482-8 10.1016/S0165-5728(00)00422-7 10.1073/pnas.0807841105 10.1016/j.neuroscience.2012.02.004 10.1016/S1474-4422(20)30136-8 10.1016/j.parkreldis.2023.105890 10.5114/fn.2013.35955 10.1038/s41380-022-01919-7 10.1093/rheumatology/kev331 10.1007/s00702-023-02704-8 10.1038/nn.4475 10.4049/jimmunol.180.6.3655 10.3109/10428199509059636 10.1016/j.mad.2009.08.003 10.1111/bjd.2015.172.issue-1 10.1084/jem.20202057 10.1212/NXI.0000000000001125 10.18632/aging.100859 10.1093/brain/awh625 10.1097/NEN.0b013e31829768d2 10.1186/1471-2105-13-86 10.1084/jem.20181124 10.3390/ijms21249384 10.3389/fimmu.2022.814239 10.1186/s12967-021-03055-2 10.1186/1742-2094-11-86 10.1038/s41590-019-0378-1 10.1084/jem.184.6.2271 10.1016/j.expneurol.2009.03.002 10.1016/j.immuni.2020.06.013 10.1038/s41531-024-00735-w 10.1038/s41577-022-00684-6 10.1001/jamaneurol.2016.2742 |
ContentType | Journal Article |
Copyright | Copyright © 2025 Ma, Wang, Yu, Zhai and Yan. Copyright © 2025 Ma, Wang, Yu, Zhai and Yan 2025 Ma, Wang, Yu, Zhai and Yan |
Copyright_xml | – notice: Copyright © 2025 Ma, Wang, Yu, Zhai and Yan. – notice: Copyright © 2025 Ma, Wang, Yu, Zhai and Yan 2025 Ma, Wang, Yu, Zhai and Yan |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2025.1526095 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_e33e4742e8e2438a92cda6cf245e653b PMC11994702 40230858 10_3389_fimmu_2025_1526095 |
Genre | Systematic Review Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IPNFZ M48 NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c422t-3ac6b67fdbf655e0b9e8e2ce75614401d8cf7a5bf9b580367d9d16fca1acfb5d3 |
IEDL.DBID | DOA |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 00:26:48 EDT 2025 Thu Aug 21 18:32:00 EDT 2025 Tue Apr 15 17:30:45 EDT 2025 Thu Apr 17 08:38:49 EDT 2025 Tue Jul 01 05:17:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | B lymphocyte B lymphocyte subsets Inflammation Pathogenesis Immunity Parkinson’s disease |
Language | English |
License | Copyright © 2025 Ma, Wang, Yu, Zhai and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c422t-3ac6b67fdbf655e0b9e8e2ce75614401d8cf7a5bf9b580367d9d16fca1acfb5d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Thiru Vanniasinkam, Charles Sturt University, Australia Edited by: Rosaria Talarico, ERN ReCONNET Coordination Team, Italy Reviewed by: Jose-Noel Ibrahim, Lebanese American University, Lebanon |
OpenAccessLink | https://doaj.org/article/e33e4742e8e2438a92cda6cf245e653b |
PMID | 40230858 |
PQID | 3190336211 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e33e4742e8e2438a92cda6cf245e653b pubmedcentral_primary_oai_pubmedcentral_nih_gov_11994702 proquest_miscellaneous_3190336211 pubmed_primary_40230858 crossref_primary_10_3389_fimmu_2025_1526095 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-03-31 |
PublicationDateYYYYMMDD | 2025-03-31 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-31 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2025 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Garfias (B32) 2022; 37 Álvarez-Luquín (B30) 2021; 19 Gruden (B22) 2011; 233 Barkholt (B11) 2012; 208 Cen (B21) 2017; 33 Armstrong (B3) 2020; 323 Cancro (B76) 2020; 38 Velounias (B28) 2022; 210 Tansey (B50) 2022; 22 Double (B79) 2009; 217 Zhang (B37) 2023; 116 Wolf (B62) 1996; 184 Bulati (B75) 2015; 44 Zhao (B38) 2020; 11 Cancro (B84) 2021; 303 Chen (B87) 2018; 169 Yan (B23) 2021; 8 Zhang (B93) 2019; 20 Feigin (B1) 2019; 18 LeBien (B18) 2008; 112 Horvath (B41) 2015; 7 Mauri (B60) 2012; 30 Brochard (B6) 2009; 119 Wang (B53) 2022; 13 Colonna-Romano (B74) 2009; 130 Matsushita (B57) 2016; 55 Scott (B14) 2023; 5 Bendall (B26) 2014; 157 Mauri (B54) 2017; 127 Horvath (B81) 2017; 8 Fyfe (B12) 2023; 19 Scholz (B65) 2008; 105 Schweighoffer (B67) 2021; 71 Siu (B92) 2022; 7 Moir (B78) 2008; 205 Scott (B17) 2022; 12 Liechti (B77) 2019; 216 Campolo (B7) 2020; 21 Castonguay (B82) 2021; 11 Bloem (B88) 2021; 397 Kalia (B89) 2015; 386 Stevens (B15) 2012; 252 Cencioni (B55) 2021; 27 Zhu (B59) 2015; 172 Bas (B31) 2001; 113 Steri (B69) 2017; 376 Theodore (B9) 2008; 67 Sanchez-Guajardo (B8) 2013; 72 Noelker (B20) 2014; 11 Magliozzi (B68) 2020; 24 Wang (B16) 2022; 13 Zhao (B39) 2024; 131 Houseman (B42) 2012; 13 Louveau (B44) 2018; 21 Volc (B83) 2020; 19 Prinz (B43) 2017; 20 Herisson (B46) 2018; 21 Xing (B61) 2015; 97 Papalexi (B91) 2018; 18 Sheng (B58) 2016; 297 Steinmetz (B2) 2024; 23 Moher (B24) 2009; 3 Morris (B86) 2024; 403 Hurny (B33) 2013; 51 Brooks (B66) 2021; 218 Glass (B90) 2020; 53 More (B19) 2013; 2013 Qin (B85) 2016; 73 Wei (B73) 2007; 178 Kedmi (B49) 2011; 6 Huntington (B70) 2006; 18 Li (B13) 2022; 9 Fillatreau (B63) 2002; 3 Foley (B48) 2023; 28 Benson (B64) 2008; 180 Lin (B56) 2022; 13 Frasca (B72) 2018; 107 Perner (B34) 2019; 16 Scott (B47) 2022; 12 Niwa (B40) 2012; 12 Balzano (B10) 2024; 10 Zou (B45) 2019; 8 Yanamandra (B80) 2011; 6 Rosser (B52) 2015; 42 Nathan (B51) 2010; 140 Rocha (B35) 2018; 55 Scheuermann (B27) 1995; 18 Stang (B25) 2010; 25 Álvarez-Luquín (B29) 2019; 16 Monahan (B4) 2008; 17 Sun (B36) 2019; 7 Seifert (B71) 2015; 112 Orr (B5) 2005; 128 |
References_xml | – volume: 67 year: 2008 ident: B9 article-title: Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease publication-title: J neuropathology Exp Neurol doi: 10.1097/NEN.0b013e31818e5e99 – volume: 2013 start-page: 952375 year: 2013 ident: B19 article-title: Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease publication-title: Mediators Inflammation doi: 10.1155/2013/952375 – volume: 140 year: 2010 ident: B51 article-title: Nonresolving inflammation publication-title: Cell doi: 10.1016/j.cell.2010.02.029 – volume: 303 start-page: 72 year: 2021 ident: B84 article-title: Memory B cells and plasma cells: The differentiative continuum of humoral immunity publication-title: Immunol Rev doi: 10.1111/imr.v303.1 – volume: 17 year: 2008 ident: B4 article-title: Neuroinflammation and peripheral immune infiltration in Parkinson’s disease: an autoimmune hypothesis publication-title: Cell Transplant doi: 10.3727/096368908784423328 – volume: 18 year: 2019 ident: B1 article-title: Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(18)30499-X – volume: 233 year: 2011 ident: B22 article-title: Immunoprotection against toxic biomarkers is retained during Parkinson’s disease progression publication-title: J neuroimmunology doi: 10.1016/j.jneuroim.2010.12.001 – volume: 19 start-page: 711 year: 2023 ident: B12 article-title: Peripheral B cells altered in Parkinson disease publication-title: Nat Rev Neurol doi: 10.1038/s41582-023-00902-2 – volume: 18 year: 2006 ident: B70 article-title: A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses publication-title: Int Immunol doi: 10.1093/intimm/dxl080 – volume: 403 start-page: 293 year: 2024 ident: B86 article-title: The pathogenesis of Parkinson’s disease publication-title: Lancet doi: 10.1016/S0140-6736(23)01478-2 – volume: 55 year: 2018 ident: B35 article-title: Reduced activated T lymphocytes (CD4+CD25+) and plasma levels of cytokines in Parkinson’s disease publication-title: Mol Neurobiol doi: 10.1007/s12035-017-0404-y – volume: 25 year: 2010 ident: B25 article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses publication-title: Eur J Epidemiol doi: 10.1007/s10654-010-9491-z – volume: 12 start-page: S75 year: 2022 ident: B17 article-title: B lymphocytes in Parkinson’s disease publication-title: J Parkinson’s Dis doi: 10.3233/JPD-223418 – volume: 157 year: 2014 ident: B26 article-title: Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development publication-title: Cell doi: 10.1016/j.cell.2014.04.005 – volume: 8 year: 2017 ident: B81 article-title: Immunochemical detection of α-synuclein autoantibodies in Parkinson’s disease: correlation between plasma and cerebrospinal fluid levels publication-title: ACS Chem Neurosci doi: 10.1021/acschemneuro.7b00063 – volume: 21 year: 2018 ident: B46 article-title: Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration publication-title: Nat Neurosci doi: 10.1038/s41593-018-0213-2 – volume: 112 year: 2008 ident: B18 article-title: B lymphocytes: how they develop and function publication-title: Blood doi: 10.1182/blood-2008-02-078071 – volume: 127 year: 2017 ident: B54 article-title: Human regulatory B cells in health and disease: therapeutic potential publication-title: J Clin Invest doi: 10.1172/JCI85113 – volume: 6 year: 2011 ident: B80 article-title: [amp]]alpha;-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson’s disease patients publication-title: PLoS One doi: 10.1371/journal.pone.0018513 – volume: 33 start-page: 493 year: 2017 ident: B21 article-title: Peripheral lymphocyte subsets as a marker of Parkinson’s disease in a Chinese population publication-title: Neurosci Bull doi: 10.1007/s12264-017-0163-9 – volume: 252 year: 2012 ident: B15 article-title: Reduced T helper and B lymphocytes in Parkinson’s disease publication-title: J neuroimmunology doi: 10.1016/j.jneuroim.2012.07.015 – volume: 37 year: 2022 ident: B32 article-title: Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson’s diseases publication-title: Neurologia doi: 10.1016/j.nrl.2018.10.004 – volume: 11 start-page: 71 year: 2021 ident: B82 article-title: Treating Parkinson’s disease with antibodies: previous studies and future directions publication-title: J Parkinson’s Dis doi: 10.3233/JPD-202221 – volume: 21 year: 2018 ident: B44 article-title: CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature publication-title: Nat Neurosci doi: 10.1038/s41593-018-0227-9 – volume: 13 year: 2022 ident: B53 article-title: Editorial: insights into regulatory B cells publication-title: Front Immunol doi: 10.3389/fimmu.2022.903711 – volume: 11 year: 2020 ident: B38 article-title: Imbalance of circulating Tfh/Tfr cells in patients with Parkinson’s disease publication-title: Front Neurol doi: 10.3389/fneur.2020.572205 – volume: 23 year: 2024 ident: B2 article-title: Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(24)00038-3 – volume: 7 year: 2022 ident: B92 article-title: Two subsets of human marginal zone B cells resolved by global analysis of lymphoid tissues and blood publication-title: Sci Immunol doi: 10.1126/sciimmunol.abm9060 – volume: 169 start-page: 1 year: 2018 ident: B87 article-title: The role of T cells in the pathogenesis of Parkinson’s disease publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2018.08.002 – volume: 12 year: 2012 ident: B40 article-title: Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson’s disease publication-title: Geriatrics gerontology Int doi: 10.1111/j.1447-0594.2011.00740.x – volume: 12 start-page: S75 year: 2022 ident: B47 article-title: B Lymphocytes in Parkinson’s Disease publication-title: J Parkinsons Dis doi: 10.3233/JPD-223418 – volume: 297 start-page: 38 year: 2016 ident: B58 article-title: Impaired regulatory B cells in myasthenia gravis publication-title: J neuroimmunology doi: 10.1016/j.jneuroim.2016.05.004 – volume: 44 year: 2015 ident: B75 article-title: Double negative (IgG+IgD-CD27-) B cells are increased in a cohort of moderate-severe Alzheimer’s disease patients and show a pro-inflammatory trafficking receptor phenotype publication-title: J Alzheimer’s disease: JAD doi: 10.3233/JAD-142412 – volume: 376 year: 2017 ident: B69 article-title: Overexpression of the cytokine BAFF and autoimmunity risk publication-title: New Engl J Med doi: 10.1056/NEJMoa1610528 – volume: 6 start-page: 66 year: 2011 ident: B49 article-title: Decreased expression of B cell related genes in leukocytes of women with Parkinson’s disease publication-title: Mol neurodegeneration doi: 10.1186/1750-1326-6-66 – volume: 397 year: 2021 ident: B88 article-title: Parkinson’s disease publication-title: Lancet (London England) doi: 10.1016/S0140-6736(21)00218-X – volume: 27 year: 2021 ident: B55 article-title: Defective CD19+CD24(hi)CD38(hi) transitional B-cell function in patients with relapsing-remitting MS publication-title: Multiple sclerosis (Houndmills Basingstoke England) doi: 10.1177/1352458520951536 – volume: 13 year: 2022 ident: B56 article-title: Regulatory B cells are decreased and functionally impaired in myasthenia gravis patients publication-title: Front Neurol doi: 10.3389/fneur.2022.808322 – volume: 24 year: 2020 ident: B68 article-title: The BAFF/APRIL system as therapeutic target in multiple sclerosis publication-title: Expert Opin Ther Targets doi: 10.1080/14728222.2020.1821647 – volume: 30 year: 2012 ident: B60 article-title: Immune regulatory function of B cells publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-020711-074934 – volume: 16 start-page: 212 year: 2019 ident: B29 article-title: Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved publication-title: J Neuroinflamm doi: 10.1186/s12974-019-1606-1 – volume: 386 start-page: 896 year: 2015 ident: B89 article-title: Parkinson’s disease publication-title: Lancet (London England) doi: 10.1016/S0140-6736(14)61393-3 – volume: 38 year: 2020 ident: B76 article-title: Age-associated B cells publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-092419-031130 – volume: 18 start-page: 35 year: 2018 ident: B91 article-title: Single-cell RNA sequencing to explore immune cell heterogeneity publication-title: Nat Rev Immunol doi: 10.1038/nri.2017.76 – volume: 7 start-page: 637 year: 2019 ident: B36 article-title: Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson’s disease publication-title: Ann Trans Med doi: 10.21037/atm.2019.10.105 – volume: 323 year: 2020 ident: B3 article-title: Diagnosis and treatment of Parkinson disease publication-title: JAMA doi: 10.1001/jama.2019.22360 – volume: 3 year: 2002 ident: B63 article-title: B cells regulate autoimmunity by provision of IL-10 publication-title: Nat Immunol doi: 10.1038/ni833 – volume: 178 year: 2007 ident: B73 article-title: A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus publication-title: J Immunol (Baltimore Md.: 1950) doi: 10.4049/jimmunol.178.10.6624 – volume: 119 year: 2009 ident: B6 article-title: Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease publication-title: J Clin Invest doi: 10.1172/JCI36470 – volume: 8 start-page: 7 year: 2019 ident: B45 article-title: Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein publication-title: Trans neurodegeneration doi: 10.1186/s40035-019-0147-y – volume: 107 year: 2018 ident: B72 article-title: Senescent B cells in aging and age-related diseases: Their role in the regulation of antibody responses publication-title: Exp gerontology doi: 10.1016/j.exger.2017.07.002 – volume: 205 year: 2008 ident: B78 article-title: Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals publication-title: J Exp Med doi: 10.1084/jem.20072683 – volume: 8 year: 2021 ident: B23 article-title: Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease publication-title: Neurology(R) neuroimmunology Neuroinflamm doi: 10.1212/NXI.0000000000001036 – volume: 71 year: 2021 ident: B67 article-title: BAFF signaling in health and disease publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2021.06.014 – volume: 112 year: 2015 ident: B71 article-title: Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1416276112 – volume: 42 year: 2015 ident: B52 article-title: Regulatory B cells: origin, phenotype, and function publication-title: Immunity doi: 10.1016/j.immuni.2015.04.005 – volume: 97 year: 2015 ident: B61 article-title: Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis publication-title: J leukocyte Biol doi: 10.1189/jlb.3A0414-213RR – volume: 210 year: 2022 ident: B28 article-title: Human B-cell subset identification and changes in inflammatory diseases publication-title: Clin Exp Immunol doi: 10.1093/cei/uxac104 – volume: 5 start-page: fcad060 year: 2023 ident: B14 article-title: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression publication-title: Brain Commun doi: 10.1093/braincomms/fcad060 – volume: 16 start-page: 94 year: 2019 ident: B34 article-title: Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease publication-title: J Neuroinflamm doi: 10.1186/s12974-019-1482-8 – volume: 113 year: 2001 ident: B31 article-title: Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism publication-title: J neuroimmunology doi: 10.1016/S0165-5728(00)00422-7 – volume: 105 year: 2008 ident: B65 article-title: BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0807841105 – volume: 208 start-page: 85 year: 2012 ident: B11 article-title: Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates publication-title: Neuroscience doi: 10.1016/j.neuroscience.2012.02.004 – volume: 19 start-page: 591 year: 2020 ident: B83 article-title: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson’s disease: a randomised, single-blinded, phase 1 trial publication-title: Lancet Neurol doi: 10.1016/S1474-4422(20)30136-8 – volume: 116 start-page: 105890 year: 2023 ident: B37 article-title: Abnormal immune function of B lymphocyte in peripheral blood of Parkinson’s disease publication-title: Parkinsonism related Disord doi: 10.1016/j.parkreldis.2023.105890 – volume: 51 year: 2013 ident: B33 article-title: Impact of L-DOPA treatment of patients with Parkinson’s disease on mononuclear subsets and phagocytosis in the peripheral blood publication-title: Folia neuropathologica doi: 10.5114/fn.2013.35955 – volume: 28 year: 2023 ident: B48 article-title: Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis publication-title: Mol Psychiatry doi: 10.1038/s41380-022-01919-7 – volume: 55 year: 2016 ident: B57 article-title: Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity publication-title: Rheumatol (Oxford England) doi: 10.1093/rheumatology/kev331 – volume: 131 start-page: 13 year: 2024 ident: B39 article-title: The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease publication-title: J Neural Transm (Vienna Austria: 1996) doi: 10.1007/s00702-023-02704-8 – volume: 20 year: 2017 ident: B43 article-title: The role of peripheral immune cells in the CNS in steady state and disease publication-title: Nat Neurosci doi: 10.1038/nn.4475 – volume: 3 year: 2009 ident: B24 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement publication-title: Open medicine: peer-reviewed independent open-access J – volume: 180 year: 2008 ident: B64 article-title: Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL publication-title: J Immunol (Baltimore Md.: 1950) doi: 10.4049/jimmunol.180.6.3655 – volume: 18 year: 1995 ident: B27 article-title: CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy publication-title: Leukemia lymphoma doi: 10.3109/10428199509059636 – volume: 130 year: 2009 ident: B74 article-title: A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people publication-title: Mech Ageing Dev doi: 10.1016/j.mad.2009.08.003 – volume: 172 year: 2015 ident: B59 article-title: Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus publication-title: Br J Dermatol doi: 10.1111/bjd.2015.172.issue-1 – volume: 218 year: 2021 ident: B66 article-title: The BAFFling persistence of memory B cells publication-title: J Exp Med doi: 10.1084/jem.20202057 – volume: 9 year: 2022 ident: B13 article-title: Abnormal B-cell and Tfh-cell profiles in patients with Parkinson disease: A cross-sectional study publication-title: Neurology(R) neuroimmunology Neuroinflamm doi: 10.1212/NXI.0000000000001125 – volume: 7 year: 2015 ident: B41 article-title: Increased epigenetic age and granulocyte counts in the blood of Parkinson’s disease patients publication-title: Aging doi: 10.18632/aging.100859 – volume: 128 year: 2005 ident: B5 article-title: A possible role for humoral immunity in the pathogenesis of Parkinson’s disease publication-title: Brain doi: 10.1093/brain/awh625 – volume: 72 year: 2013 ident: B8 article-title: [amp]]alpha;-Synuclein vaccination prevents the accumulation of Parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model publication-title: J neuropathology Exp Neurol doi: 10.1097/NEN.0b013e31829768d2 – volume: 13 start-page: 86 year: 2012 ident: B42 article-title: DNA methylation arrays as surrogate measures of cell mixture distribution publication-title: BMC Bioinf doi: 10.1186/1471-2105-13-86 – volume: 216 year: 2019 ident: B77 article-title: Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells publication-title: J Exp Med doi: 10.1084/jem.20181124 – volume: 21 start-page: 9384 year: 2020 ident: B7 article-title: TLR7/8 in the pathogenesis of Parkinson’s disease publication-title: Int J Mol Sci doi: 10.3390/ijms21249384 – volume: 13 year: 2022 ident: B16 article-title: Global characterization of peripheral B cells in Parkinson’s disease by single-cell RNA and BCR sequencing publication-title: Front Immunol doi: 10.3389/fimmu.2022.814239 – volume: 19 start-page: 378 year: 2021 ident: B30 article-title: Increased Tc17 cell levels and imbalance of naïve/effector immune response in Parkinson’s disease patients in a two-year follow-up: a case control study publication-title: J Trans Med doi: 10.1186/s12967-021-03055-2 – volume: 11 start-page: 86 year: 2014 ident: B20 article-title: Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease publication-title: J Neuroinflamm doi: 10.1186/1742-2094-11-86 – volume: 20 year: 2019 ident: B93 article-title: Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry publication-title: Nat Immunol doi: 10.1038/s41590-019-0378-1 – volume: 184 year: 1996 ident: B62 article-title: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice publication-title: J Exp Med doi: 10.1084/jem.184.6.2271 – volume: 217 start-page: 297 year: 2009 ident: B79 article-title: Anti-melanin antibodies are increased in sera in Parkinson’s disease publication-title: Exp Neurol doi: 10.1016/j.expneurol.2009.03.002 – volume: 53 year: 2020 ident: B90 article-title: An integrated multi-omic single-cell atlas of human B cell identity publication-title: Immunity doi: 10.1016/j.immuni.2020.06.013 – volume: 10 start-page: 118 year: 2024 ident: B10 article-title: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates publication-title: NPJ Parkinson’s Dis doi: 10.1038/s41531-024-00735-w – volume: 22 year: 2022 ident: B50 article-title: Inflammation and immune dysfunction in Parkinson disease publication-title: Nat Rev Immunol doi: 10.1038/s41577-022-00684-6 – volume: 73 year: 2016 ident: B85 article-title: Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: A systematic review and meta-analysis publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2016.2742 |
SSID | ssj0000493335 |
Score | 2.3976185 |
SecondaryResourceType | review_article |
Snippet | The association of B lymphocytes and B lymphocyte subsets and Parkinson's disease (PD) is increasingly acknowledged. However, there is inconsistence in the... ObjectiveThe association of B lymphocytes and B lymphocyte subsets and Parkinson’s disease (PD) is increasingly acknowledged. However, there is inconsistence... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 1526095 |
SubjectTerms | B lymphocyte B lymphocyte subsets B-Lymphocyte Subsets - immunology B-Lymphocyte Subsets - metabolism B-Lymphocytes - immunology Biomarkers Humans Immunity Immunology Inflammation Lymphocyte Count Parkinson Disease - blood Parkinson Disease - immunology Parkinson’s disease Pathogenesis |
Title | Aberrations in peripheral B lymphocytes and B lymphocyte subsets levels in Parkinson disease: a systematic review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40230858 https://www.proquest.com/docview/3190336211 https://pubmed.ncbi.nlm.nih.gov/PMC11994702 https://doaj.org/article/e33e4742e8e2438a92cda6cf245e653b |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQUiUuVVtoSV8yErcqIvEjiXuDqoCQ4ATS3iw_xVZLtmV3D_vvO2MH2FSVuHDJwc7Dmm_imU_2fCbksPImKtZWpTctEBQAtrQNC6VxzHhwESdSLczlVXN-Iy4mcrJx1BfuCcvywNlwR4HzIIC_hS4wwTujmPOmcZEJGRrJLc6-EPM2yNSvnPdyzmWukgEWpo7i9O5uBXyQSTzyB2XWRpEoCfb_L8v8d7PkRvQ5fUNeD2kjPc7DfUu2Qv-OvMoHSa53yZ9jG-4zlgs67SnKFye9gBk9obM1IDZ3a0gqqen9qIUuYOIIywWd4eah9CzWQaeSMDos3nynhj4JPtNc7LJHbk5_Xv84L4fDFEonGFuW3LjGNm30NjZShsoqtKgLLUqBAsnynYutkTYqKzsIa61Xvm6iM7Vx0UrP35Ptft6HfUI99AbpuPIyitY7JT28y0rrlXGV4AX59mBY_TtrZmjgGgiDTjBohEEPMBTkBG3_eCfqXacG8AI9eIF-zgsKcvCAnIb_Axc9TB_mq4WGKabiEKXruiAfMpKPnxJIwDrZFaQbYTway7inn94mDe4aNZXbin18idF_IjtokVzq-JlsL-9X4QvkOkv7Nbk1XM8m9V9OnAIY |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aberrations+in+peripheral+B+lymphocytes+and+B+lymphocyte+subsets+levels+in+Parkinson+disease%3A+a+systematic+review&rft.jtitle=Frontiers+in+immunology&rft.au=Ma%2C+Hongxia&rft.au=Wang%2C+Ziyuan&rft.au=Yu%2C+Miao&rft.au=Zhai%2C+Yibo&rft.date=2025-03-31&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=16&rft_id=info:doi/10.3389%2Ffimmu.2025.1526095&rft.externalDocID=PMC11994702 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |